IRCT2017050333789N1已完成2 期
Assessment of efficacy of weekly paclitaxel as a neoadjuvant chemotherapy in advanced ovarian cancers
Taleghani Hospital- Shahid Beheshti University of Medical Sciences0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Female
入选标准
- •Age over 18yr; Ovarian cancer confirmed by biopsy and pathology; Advanced disease confirmed by CT scan (Stage III or IV); No previous history of chemotherapy; Good liver and lung functional status; No candidate for primary surgery due to underlying disease; Full access to patients medical documents; Patient satisfaction for study participation
排除标准
- 未提供
研究者
相似试验
尚未招募
2 期
ow dose cancer drugs for advanced stomach cancerCTRI/2022/11/047033JIPMER PONDICHERRY
招募中
2 期
A study of low intensity chemotherapy in relapsed and refractory lymphoma patientsCTRI/2020/08/026992Jawaharlal Institute Post Graduate Medical Education and Research
已完成
2 期
A phase II study of weekly paclitaxel for advanced or recurrent esophageal canceradvanced or reccurent esophageal cancerJPRN-UMIN000009807Medical Oncology, Hirosaki University Graduate School of Medicine30
招募中
2 期
Improving Performance status of Advanced lung cancer patients with ChemotherapyCTRI/2020/01/022617All India Institute of Medical Sciences
已完成
2 期
Comparison of efficacy of Paclitaxel with Cisplatin when given weekly along with radiation in patients suffering from Head and Neck cancers.CTRI/2017/09/009864Jawaharlal Institute of Post Graduate Medical Education and Research54